Download our latest Annual Report - Bakkavor
Download our latest Annual Report - Bakkavor
Download our latest Annual Report - Bakkavor
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
BAKKAVOR ANNUAL REPORT AND ACCOUNTS 2012<br />
directors’ report<br />
THE DIRECTORS PRESENT THEIR ANNUAL REPORT ON<br />
THE AFFAIRS OF THE BAKKAVOR FINANCE (2) PLC GROUP<br />
(THE “GROUP”).<br />
This is accompanied by the financial statements<br />
and Auditor’s report for the 52 weeks ended<br />
29 December 2012. Comparatives are for the 52<br />
weeks ended 31 December 2011.<br />
index to principal directors’ report disclosures<br />
Auditor 48<br />
Board of Directors 52<br />
Charitable donations 52<br />
Creditor payment policy 52<br />
Directors’ responsibilities 52<br />
Disclosure of information to Auditor 48<br />
Employee involvement 39<br />
Employees with disabilities 52<br />
Equal opportunities 52<br />
Going concern 51<br />
Political donations 52<br />
Principal activities 51<br />
Profit 51<br />
Dividends 52<br />
PRINCIPAL ACTIVITIES<br />
The Group is a leading provider of fresh prepared food products in the<br />
United Kingdom. Our customers include some of the United Kingdom’s<br />
most reputable and well-known grocery retailers, including Tesco, Marks<br />
& Spencer, J Sainsbury, Waitrose, Asda and Morrisons, which sell <strong>our</strong><br />
products to their customers predominantly under their respective private<br />
labels. We have also established a significant presence in development<br />
markets for fresh prepared and private label food products, including<br />
Europe, the United States and China. The subsidiaries principally<br />
affecting the profits or net assets of the Group in the period are listed in<br />
Note 8 to the Company only financial statements.<br />
RESULTS FOR THE YEAR<br />
The results of the Group for the year are set out in the Group income<br />
statement. The profit for the year after taxation and exceptional items<br />
was £2.1 million (2011: loss after tax of £75.0 million). Further details of<br />
the Group’s financial performance are outlined in the Business Review.<br />
GOING CONCERN<br />
The Directors, in their detailed consideration of going concern, have<br />
reviewed the Group’s future cash forecasts and revenue projections,<br />
which they believe are based on prudent market data and past<br />
experience, and believe, based on those forecasts and projections, that<br />
it is appropriate to prepare the financial statements of the Company and<br />
the Group on a going concern basis.<br />
In arriving at this conclusion the Directors considered the Group’s<br />
financing arrangements, which comprise £350 million of seven-year<br />
listed bonds issued in February 2011 and £350 million of bank facilities<br />
committed to June 2014. The Company is in advanced discussions<br />
with its lenders regarding the refinancing of these bank facilities. Both<br />
the Company and its lenders are committed to the refinancing of both<br />
the term loan and revolving credit facility and the Board is confident of<br />
announcing new financing arrangements in the near future.<br />
Importantly, the Group’s liquidity remains particularly strong with<br />
£83.8 million of facilities undrawn as at 29 December 2012.<br />
The existing bank facilities are subject to a series of covenants set by<br />
the lenders. Financial covenants are measured quarterly and include an<br />
assessment of leverage (the ratio of net debt to EBITDA, being earnings<br />
before interest, tax, depreciation and amortisation); cash flow cover (the<br />
ratio of finance charges to cash generated from operations); interest<br />
cover (the ratio of finance charges to EBITDA); and capital expenditure<br />
limits. The key financial covenant is leverage; this was re-set earlier in<br />
the year following the successful restructuring of the Company’s parent.<br />
Under the revised covenant, leverage must be less than 5.75 times at<br />
the 2012 financial year-end and less than 5.0 times at the 2013 financial<br />
year-end. At 29 December 2012 the leverage ratio of net debt to EBITDA<br />
was 4.9 times. At the date of this report the Group has complied in<br />
all respects with the terms of its borrowing agreements, including its<br />
financial covenants, and forecasts to continue to do so.<br />
The Group believes it is adequately placed to manage covenant<br />
compliance successfully despite the challenging macroeconomic<br />
environment. In the event that conditions worsen, the Group has the<br />
flexibility to react by accessing additional working capital arrangements<br />
that we have already agreed with key stakeholders. Further actions<br />
available to management may include a reduction to <strong>our</strong> capital<br />
expenditure programme and further supply chain improvements.<br />
Consequently, the Directors have a reasonable expectation that the<br />
Company and the Group have adequate res<strong>our</strong>ces to comply with these<br />
covenants and meet their liabilities as they fall due for a period of at<br />
least 12 months from the date of approval of the financial statements.<br />
For this reason, they continue to adopt the going concern basis in<br />
preparing the financial statements.<br />
FUTURE DEVELOPMENTS<br />
As we enter the new financial year, the ongoing macroeconomic<br />
pressures on consumers and retailers combined with further inflation<br />
on raw material prices remain a challenge for the business. Despite this,<br />
the Directors are of the opinion that the strategic actions implemented<br />
in the current year, coupled with capacity and productivity investments<br />
across the Group, leave the Company in a stronger position to compete<br />
with these economic pressures. Further detail on future prospects are<br />
outlined in the Chairman’s Address and the Business Review.<br />
RESEARCH AND DEVELOPMENT<br />
The main focus of the Group’s research and development expenditure is<br />
product innovation. Research and development expenditure increased by<br />
14.5% to £6.3 million in 2012 (2011: £5.5 million).<br />
PAGE 51 VIEW THE FULL REPORT AT ANNUALREPORT12.BAKKAVOR.COM